{"brief_title": "Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer", "brief_summary": "This is a nonrandomized study of pemetrexed plus carboplatin, with the primary objective of determining the efficacy of the combination in tumor reduction, in patients with locally advanced or metastatic breast cancer.", "condition": "Neoplasm Metastasis", "intervention_type": "Drug", "intervention_name": "Carboplatin", "criteria": "Inclusion Criteria: - Histologic or cytologic diagnosis of locally advanced or metastatic breast cancer - No prior chemotherapy for locally advanced or metastatic breast disease. - Patient may have received prior adjuvant therapy finished greater than 1 year prior to enrollment. - Adequate bone marrow, liver and kidney function - RECIST criteria for disease status Exclusion Criteria: - Prior treatment with pemetrexed - Pregnant or breast feeding - Brain Metastasis - unable or unwilling to take folic acid, vitamin B12 supplementation, or dexamethasone.", "gender": "Female", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00072865.xml"}